Clinical Trial Update: Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a regimen of bortezomib with gemcitabine, ifosfamide and oxaliplatin in untreated Extranodal NK/T-cell lymphoma was terminated. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)
• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Extranodal NK-T-CELL LYMPHOMA | Phase 2 | Status: TERMINATED